2.115
price down icon3.86%   -0.085
after-market Handel nachbörslich: 2.10 -0.015 -0.71%
loading
Schlusskurs vom Vortag:
$2.20
Offen:
$2.16
24-Stunden-Volumen:
14,340
Relative Volume:
0.20
Marktkapitalisierung:
$25.81M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-3.15M
KGV:
-6.9299
EPS:
-0.3052
Netto-Cashflow:
$-2.23M
1W Leistung:
-12.60%
1M Leistung:
+5.22%
6M Leistung:
-8.84%
1J Leistung:
-8.24%
1-Tages-Spanne:
Value
$2.09
$2.17
1-Wochen-Bereich:
Value
$2.09
$2.45
52-Wochen-Spanne:
Value
$1.65
$4.0499

Cytomed Therapeutics Ltd Stock (GDTC) Company Profile

Name
Firmenname
Cytomed Therapeutics Ltd
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
34
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
GDTC's Discussions on Twitter

Vergleichen Sie GDTC mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
GDTC
Cytomed Therapeutics Ltd
2.115 25.81M 0 -3.15M -2.23M -0.3052
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.00 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
642.25 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
434.07 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
826.28 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
186.23 40.44B 447.02M -1.18B -868.57M -6.1812

Cytomed Therapeutics Ltd Aktie (GDTC) Neueste Nachrichten

pulisher
09:57 AM

Can CytoMed Therapeutics Limited stock deliver surprise earnings beatJuly 2025 Final Week & Verified Momentum Stock Watchlist - newser.com

09:57 AM
pulisher
02:52 AM

CytoMed Therapeutics Limited stock trend outlook and recovery path2025 Breakouts & Breakdowns & Free Reliable Trade Execution Plans - newser.com

02:52 AM
pulisher
Nov 02, 2025

CytoMed Therapeutics Limited recovery potential after sell offGap Up & Weekly Return Optimization Plans - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is a relief rally coming for CytoMed Therapeutics Limited holdersTrade Risk Summary & Free Growth Oriented Trading Recommendations - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Will CytoMed Therapeutics Limited stock split attract more investorsMarket Sentiment Report & Growth Focused Stock Reports - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

What earnings revisions data tells us about CytoMed Therapeutics Limited2025 Volume Leaders & Intraday High Probability Setup Alerts - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Chart based analysis of CytoMed Therapeutics Limited trendsDividend Hike & Long-Term Growth Plans - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Can CytoMed Therapeutics Limited (F98) stock sustain double digit ROEJuly 2025 Volume & Daily Entry Point Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Using fundamentals and technicals on CytoMed Therapeutics LimitedSell Signal & Technical Pattern Recognition Alerts - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

What MACD and RSI say about CytoMed Therapeutics Limited2025 Geopolitical Influence & Growth Focused Entry Reports - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

CytoMed Therapeutics Limited stock outlook for YEARWeekly Investment Report & Community Trade Idea Sharing - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Will CytoMed Therapeutics Limited (F98) stock keep high P E multiplesJuly 2025 Reactions & Free Safe Capital Growth Stock Tips - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

How CytoMed Therapeutics Limited (F98) stock responds to bond marketCEO Change & Long-Term Safe Investment Plans - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Should you wait for a breakout in CytoMed Therapeutics Limited2025 Risk Factors & Expert Approved Momentum Ideas - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Why CytoMed Therapeutics Limited stock appeals to dividend seekersJuly 2025 Spike Watch & Real-Time Chart Breakout Alerts - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Long term hold vs stop loss in CytoMed Therapeutics Limited2025 Price Targets & High Accuracy Trade Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Why CytoMed Therapeutics Limited stock could benefit from AI revolution2025 Valuation Update & Long Hold Capital Preservation Tips - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Published on: 2025-10-25 16:06:34 - newser.com

Oct 28, 2025
pulisher
Oct 27, 2025

What does recent volatility data suggest for CytoMed Therapeutics Limited2025 Volume Leaders & Fast Entry Momentum Alerts - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

What recovery options are there for CytoMed Therapeutics LimitedEarnings Summary Report & Free Real-Time Market Sentiment Alerts - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

What insider purchases suggest about CytoMed Therapeutics Limited (F98) stockJuly 2025 Momentum & Weekly Market Pulse Alerts - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Can you recover from losses in CytoMed Therapeutics Limited2025 Technical Patterns & Consistent Profit Trade Alerts - newser.com

Oct 27, 2025
pulisher
Oct 26, 2025

Heatmap analysis for CytoMed Therapeutics Limited and competitorsPortfolio Update Report & Precise Buy Zone Identification - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Can CytoMed Therapeutics Limited recover in the next quarter2025 Big Picture & Scalable Portfolio Growth Ideas - newser.com

Oct 26, 2025

Finanzdaten der Cytomed Therapeutics Ltd-Aktie (GDTC)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
Kapitalisierung:     |  Volumen (24h):